AVANOS MEDICAL INC (AVNS) — insider trading
Health Care · NYSE
AVANOS MEDICAL INC (AVNS) has 16 reported SEC Form 4 insider transactions in our data (latest 2026-05-08).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-08 | Shimer Julie Ann | Director | Grant / award / vesting (derivative) | 12,003 | $0.00 | $0 | Form 4 |
| 2026-05-08 | OLEARY PATRICK J | Director | Grant / award / vesting (derivative) | 12,003 | $0.00 | $0 | Form 4 |
| 2026-05-08 | Franchini Indrani Lall | Director | Grant / award / vesting (derivative) | 12,003 | $0.00 | $0 | Form 4 |
| 2026-05-08 | Egbuonu-Davis Lisa | Director | Grant / award / vesting (derivative) | 12,003 | $0.00 | $0 | Form 4 |
| 2026-05-08 | BLACKFORD GARY | Director | Grant / award / vesting (derivative) | 12,003 | $0.00 | $0 | Form 4 |
| 2026-04-22 | Delgado Sigfrido | Officer (SVP, Operations) | Shares withheld for taxes / exercise cost | 4,264 | $24.64 | $105.1K | Form 4 |
| 2026-04-22 | Galovan Scott Michael | Officer (SVP, Chief Financial Officer) | Shares withheld for taxes / exercise cost | 4,228 | $24.64 | $104.2K | Form 4 |
| 2026-04-14 | Pacitti David | Officer (Chief Executive Officer) | Shares withheld for taxes / exercise cost | 21,194 | $14.53 | $307.9K | Form 4 |
| 2026-03-13 | Delgado Sigfrido | Officer (SVP, Operations) | Grant / award / vesting (derivative) | 37,782 | $0.00 | $0 | Form 4/A |
| 2026-03-13 | Delgado Sigfrido | Officer (SVP, Operations) | Grant / award / vesting | 15,886 | $0.00 | $0 | Form 4/A |
| 2026-03-13 | Pacitti David | Officer (Chief Executive Officer) | Grant / award / vesting (derivative) | 239,354 | $0.00 | $0 | Form 4/A |
| 2026-03-13 | Pacitti David | Officer (Chief Executive Officer) | Grant / award / vesting | 101,341 | $0.00 | $0 | Form 4/A |
| 2026-03-13 | Galovan Scott Michael | Officer (SVP, Chief Financial Officer) | Grant / award / vesting (derivative) | 69,630 | $0.00 | $0 | Form 4/A |
| 2026-03-13 | Galovan Scott Michael | Officer (SVP, Chief Financial Officer) | Grant / award / vesting | 29,481 | $0.00 | $0 | Form 4/A |
| 2026-03-13 | Delgado Sigfrido | Officer (SVP, Operations) | Grant / award / vesting (derivative) | 37,520 | $0.00 | $0 | Form 4/A |
| 2026-03-13 | Delgado Sigfrido | Officer (SVP, Operations) | Grant / award / vesting | 15,886 | $0.00 | $0 | Form 4/A |
Ask the chat about AVNS's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: AVANOS MEDICAL INC (AVNS).
Last updated 2026-05-08 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.